Dutch Armed Forces / Royal Dutch Navy
Dr Stef Stienstra is a Strategic and creative development manager in biomedical science, with a parallel career as a reserve commander of the Royal Dutch Navy. For the Dutch Armed Forces he has a responsibility in the counter measures in CBNRe threats and consequence management both in a military and in a civilian (terrorism) context. In his civil career he works internationally as consultant or as scientific supervisory board member for several medical and biotech companies. At this moment for MT-Derm in Berlin (D) developing a novel intradermal vaccination technology, IQ Therapeutics in Groningen (NL) developing therapeutic antibodies against anthrax and orthopox viruses, Hemacon in Düsseldorf (D) developing a field donor blood separation and blood transfusion unit, Infection Control in Eemnes (NL) developing a bio-disinfection system for bioterrorism consequence management and IB Consulting in The Hague (NL) for biodefense projects. He has finished his studies Medicine and Biochemistry in The Netherlands and has extensive practical experience in cell biology, immuno-haematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.
CBRN defense, (therapeutic) vaccines, trauma healthcare, blood transfusion, sailing